BILL.COM HOLDINGS INC (BILL)       125.92  +0.18 (+0.14%)

125.92  +0.18 (+0.14%)

US0900431000 - Common Stock


Fundamental Rating

3

Taking everything into account, BILL scores 3 out of 10 in our fundamental rating. BILL was compared to 364 industry peers in the Software industry. Both the profitability and financial health of BILL have multiple concerns. BILL is valued quite expensive, but it does show an excellent growth.




Profitability

Profitability Rating

2

BILL's Return On Assets of -3.53% is amongst the best of the industry. BILL does better than the industry average Return On Assets of -9.75%.
BILL has negative profitability rations, so we won't be analyzing them here.

BILL has a Profit Margin of -50.84%. This is below the industry average of -19.56%.
BILL has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of BILL.
VS Industry

ROA (-3.53%) VS Industry: 64% outperformed.

-1,731.36
102.42

Profit Margin (-50.84%) VS Industry: 28% outperformed.

-66,950.88
351.03

Valuation

Valuation Rating

1

When comparing the current price to the book value of BILL, we can conclude it is valued correctly. It is trading at 3.26 times its book value.
When comparing the price book ratio of BILL to the average industry price book ratio of 3.14, BILL is valued in line with its industry peers.
The Price/Earnings Ratio is negative for BILL. In the last year negative earnings were reported.

The Forward Price/Earnings Ratio of 415.73 indicates a quite expensive current valuation of BILL.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
VS Industry

Price/Book (3.26) VS Industry: 48% outperformed.

420.86
0.12

Growth

Growth Rating

7

Based on estimates for the next 5 years, BILL will show a very strong growth in Earnings Per Share. The EPS will grow by 63.62% on average per year.
The Revenue has grown by 169.42% in the past year. This is a very strong growth!
Measured over the past 5 years, BILL shows a very strong growth in Revenue. The Revenue has been growing by 77.34% on average per year.

The Revenue is expected to grow by 36.12% on average over the next 5 years. This is a very strong growth
The earnings per share for BILL have decreased strongly by -62.50% in the last year.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -62.5% 216.5% 107.33% 75.03% 63.62%
Revenue77.34% 80.92% 169.42% 54.53% 43.4% 39.49% 36.12%

Health

Health Rating

3

A Current Ratio of 1.84 indicates that BILL should not have too much problems paying its short term obligations.
BILL has a Current Ratio comparable to the industry average, which is at 1.82.
BILL has a Quick Ratio of 1.84. This is a normal value and indicates that BILL is financially healthy and should not expect problems in meeting its short term obligations.
BILL has a Quick Ratio comparable to the industry average, which is at 1.81.

BILL has a Altman-Z score comparable to the industry average, which is at 1.99.
Compared to an average industry Debt to Equity Ratio of 0.04, BILL is more dependent on financing than its industry peers.
Based on the Altman-Z score of 1.76, we must say that BILL is in the distress zone and has some risk of bankruptcy.
The Piotroski-F score of BILL is 3.00. This is a low score and indicates issues in the health and profitability of BILL.
VS Industry

Debt/Equity (0.42) VS Industry: 28% outperformed.

84.85
0.00

Quick Ratio (1.84) VS Industry: 51% outperformed.

0.05
219.77

Current Ratio (1.84) VS Industry: 50% outperformed.

0.05
219.77

Altman-Z (1.76) VS Industry: 48% outperformed.

-181.31
156.37

Dividend

Dividend Rating

0

No dividends for BILL!.

BILL Daily chart

BILL.COM HOLDINGS INC125.92

NYSE:BILL (9/26/2022, 10:40:02 AM)+0.18 (+0.14%)

Chartmill FA Rating
GICS Sector Information Technology
GICS IndustryGroup Software & Services
GICS Industry Software
Earnings (Last) 08-18 2022-08-18/amc Earnings (Next) 11-02 2022-11-02
Ins Owners 0.38% Inst Owners 97.28%
Market Cap 13.20B Analysts 84.62
Valuation
PE N/A Fwd PE 415.73
PEG (NY) N/A PEG (5Y) N/A
P/S 20.56 P/B 3.26
EV/EBITDA -52.55
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -62.5% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 57.14%
EPS Next Y 216.5% EPS Next 2Y 107.33%
EPS Next 3Y 75.03% EPS Next 5Y 63.62%
Revenue growth 1Y 169.42% Revenue growth 3Y 80.92%
Revenue growth 5Y 77.34% Revenue growth Q2Q 155.8%
Revenue Next Year 54.53% Revenue Next 2Y 43.4%
Revenue Next 3Y 39.49% Revenue Next 5Y 36.12%
Health
Current Ratio 1.84 Quick Ratio 1.84
Altman-Z 1.76 F-Score 3
Debt/Equity 0.42
Profitability
ROA -3.53% ROE N/A
ROIC N/A ROICg N/A
PM -50.84 OM -49.35
Asset Turnover 0.07

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA